INS (preproinsulin gene) mutations, which cause hyperinsulinemia by promoting the production of structurally defective insulin, have been linked to T1DM and T2DM, and neonatal diabetes other than MODY10 [82,83]. Here, INS is linked to type 1 diabetes mellitus.